Guerbet
Healthcare · EUR · EPA
Price
€10.58
Cap
€156.52M
Earnings
—
30d Trend
-14.1%
33% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 57×Macro 0.99 (−1%)=56
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%
BRAIN47 HORIZON ANALYSIS
Long-term compounder with 4.0% yield
BRAIN47'S ASSESSMENT
I rate Guerbet at 56/100 — a STRONG reading on the Brain47 Signal. The strongest factor is quality at 64/100. I classify this as a income position with the strongest thesis on a long-term horizon.
PAST PERFORMANCE
1 MONTH
+1.0%
3 MONTHS
-2.4%
12 MONTHS
+7.6%
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
Long-term compounder with 4.0% yield. Quality (64) and low-risk profile are the primary strengths. Historical volatility is moderate at 33%. I classify this as an income position — the 4.0% yield combined with the dividend profile makes it suitable for income generation.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.